InvestorsHub Logo
Followers 25
Posts 814
Boards Moderated 0
Alias Born 05/17/2006

Re: None

Tuesday, 11/24/2020 2:33:41 PM

Tuesday, November 24, 2020 2:33:41 PM

Post# of 54915
tax selling is of course an option for many because pred has been a super "dog", BUT you will need to buy back in 30 days if you so decide so it is not considered a "wash" sale.
One assumes that you are correct that there will be no news until the next Q report due Feb 15th, BUT you have to believe that things are in the works to rid itself from the grey market!
The haters think that management has given up and is heading toward BK!
This is not true. The grey market has ruined this stock management has not!
FINRA has ruined this stock by not letting them re surface. This cmpy
uses the number 1 auditor in the USA. It is a disgrace that FINRA scum will not let them leave.
The near term remedy is merge into another trading vehicle, nasdaq shell or SPAC or even a fully reporting otc shell. There are options and eventually management will have a echoice.
I do not know the ramp levels except i did know at one point in time there was a fully shift doing the testing of saliva. The recent Q just released shows the $1 million in sales from testing so you could figure out that it was around 1000/day give or take. I can only assume they have ramped up, but do they have the contacts for growth in that segment? I assume because of their stem cell business that they supply to can supply them with potential biz! Concerning the WJ Flow - i believe that this is taking the place of the corecyte that was 73% of stem cell sales. I understand that this was developed BUT not sold until recently because of cost, which recently has come down dramatically and has a strong backlog in the Queue. This product is much better!
The current market cap is not and does not fairly represent the underlining value of pred! Markets are not very efficient when trading on the greys. Very limited amount of players, BUT plenty of haters.

snakes alive